Analyst Ratings for CytomX Therapeutics (CTMX)
CTMX Rating Summary
CTMX Price Target Summary
- Highest: $16.00 (Jefferies)
- Lowest: $3.50 (Wolfe Research)
- Average: $11.94
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$11.94 (+304.9%)
* Over Last 12-Mos
Rating Score: 7.8 / 10
Percentile Rank: 82%
Rating Score: 7.8 / 10
Percentile Rank: 82%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/19/2026 | Wolfe Research | Kalpit Patel | New Coverage | Outperform (N/A) |
3.50 (N/A) |
3.50 (2.95) |
-15.71% | Details |
| 3/16/2026 | JPMorgan | Anupam Rama | Upgrade | Overweight (Neutral) |
12.00 (7.00) |
4.68 (2.95) |
-36.97% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
